Shandong Wohua Pharmaceutical Co Ltd (002107) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Shandong Wohua Pharmaceutical Co Ltd (002107) has a cash flow conversion efficiency ratio of 0.036x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥27.12 Million ≈ $3.97 Million USD) by net assets (CN¥760.19 Million ≈ $111.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. View Shandong Wohua Pharmaceutical Co Ltd (002107) stock price for real-time trading data and today's change.
Shandong Wohua Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2003–2025)
This chart illustrates how Shandong Wohua Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Also see 002107 company net worth for the company's overall valuation and market capitalisation.
Shandong Wohua Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Shandong Wohua Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency. Also see total assets of Shandong Wohua Pharmaceutical Co Ltd for a full breakdown of the balance sheet.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SECHE ENVIRO.UNSP.ADR 1/5
F:SCB0
|
N/A |
|
Anhui Wanyi Science and Technology Co Ltd
SHG:688600
|
0.066x |
|
WINBO-Dongjian Automotive Technology Co. Ltd.
SHE:300978
|
0.079x |
|
Wuxi Commercial Mansion Grand Orient Co Ltd
SHG:600327
|
0.036x |
|
Zhejiang Red Dragonfly Footwear Co Ltd
SHG:603116
|
-0.006x |
|
Comp SA
WAR:CMP
|
-0.060x |
|
Dook Media Group Limited
SHE:301025
|
N/A |
|
Brilliance Technology Co Ltd
SHE:300542
|
-0.164x |
Annual Cash Flow Conversion Efficiency for Shandong Wohua Pharmaceutical Co Ltd (2003–2025)
The table below shows the annual cash flow conversion efficiency of Shandong Wohua Pharmaceutical Co Ltd from 2003 to 2025. Review financial flexibility index of Shandong Wohua Pharmaceutical Co Ltd to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | CN¥720.90 Million ≈ $105.49 Million |
CN¥128.53 Million ≈ $18.81 Million |
0.178x | +40.85% |
| 2024-12-31 | CN¥722.93 Million ≈ $105.79 Million |
CN¥91.51 Million ≈ $13.39 Million |
0.127x | -18.37% |
| 2023-12-31 | CN¥833.48 Million ≈ $121.96 Million |
CN¥129.25 Million ≈ $18.91 Million |
0.155x | -33.89% |
| 2022-12-31 | CN¥789.79 Million ≈ $115.57 Million |
CN¥185.26 Million ≈ $27.11 Million |
0.235x | +8.92% |
| 2021-12-31 | CN¥929.26 Million ≈ $135.98 Million |
CN¥200.12 Million ≈ $29.28 Million |
0.215x | +0.57% |
| 2020-12-31 | CN¥918.01 Million ≈ $134.33 Million |
CN¥196.58 Million ≈ $28.77 Million |
0.214x | +424.35% |
| 2019-12-31 | CN¥775.15 Million ≈ $113.43 Million |
CN¥31.66 Million ≈ $4.63 Million |
0.041x | -73.66% |
| 2018-12-31 | CN¥695.78 Million ≈ $101.81 Million |
CN¥107.88 Million ≈ $15.79 Million |
0.155x | -17.92% |
| 2017-12-31 | CN¥655.78 Million ≈ $95.96 Million |
CN¥123.88 Million ≈ $18.13 Million |
0.189x | +48.37% |
| 2016-12-31 | CN¥572.64 Million ≈ $83.79 Million |
CN¥72.91 Million ≈ $10.67 Million |
0.127x | -47.54% |
| 2015-12-31 | CN¥547.26 Million ≈ $80.08 Million |
CN¥132.82 Million ≈ $19.44 Million |
0.243x | +476.90% |
| 2014-12-31 | CN¥631.74 Million ≈ $92.44 Million |
CN¥26.58 Million ≈ $3.89 Million |
0.042x | +67.96% |
| 2013-12-31 | CN¥605.04 Million ≈ $88.54 Million |
CN¥15.15 Million ≈ $2.22 Million |
0.025x | -56.03% |
| 2012-12-31 | CN¥594.41 Million ≈ $86.98 Million |
CN¥33.86 Million ≈ $4.95 Million |
0.057x | +2351.16% |
| 2011-12-31 | CN¥586.07 Million ≈ $85.76 Million |
CN¥1.36 Million ≈ $199.29K |
0.002x | +108.98% |
| 2010-12-31 | CN¥590.64 Million ≈ $86.43 Million |
CN¥-15.28 Million ≈ $-2.24 Million |
-0.026x | +16.14% |
| 2009-12-31 | CN¥688.45 Million ≈ $100.74 Million |
CN¥-21.24 Million ≈ $-3.11 Million |
-0.031x | -155.30% |
| 2008-12-31 | CN¥637.88 Million ≈ $93.34 Million |
CN¥35.59 Million ≈ $5.21 Million |
0.056x | +82.60% |
| 2007-12-31 | CN¥342.22 Million ≈ $50.08 Million |
CN¥10.46 Million ≈ $1.53 Million |
0.031x | -90.54% |
| 2006-12-31 | CN¥142.57 Million ≈ $20.86 Million |
CN¥46.05 Million ≈ $6.74 Million |
0.323x | +175.75% |
| 2005-12-31 | CN¥111.06 Million ≈ $16.25 Million |
CN¥13.01 Million ≈ $1.90 Million |
0.117x | -71.34% |
| 2004-12-31 | CN¥82.62 Million ≈ $12.09 Million |
CN¥33.77 Million ≈ $4.94 Million |
0.409x | +16.24% |
| 2003-12-31 | CN¥51.69 Million ≈ $7.56 Million |
CN¥18.17 Million ≈ $2.66 Million |
0.352x | -- |
About Shandong Wohua Pharmaceutical Co Ltd
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. The company produces and sells tablets, granules, capsules, oral liquid, and pills; medicinal herb cultivation; and provides pharmaceutical technology consulting services. It also offers products including drugs for cardiovascular, cerebrovascular, and nervous system diseases, such as Wohua Xinkeshu t… Read more